This project aims to develop and test a mobile health (mHealth) intervention designed for caregivers of young adults with early psychosis who are unengaged in services, and specifically to examine whether it can help aid caregiver treatment facilitation.
Patient Population: Adults
Feasibility of mHealth technology-enabled service for remote observed therapy of methadone and COVID-19 screening for patients in an opioid treatment program
This small business technology transfer grant will test the feasibility and usability of a smartphone mHealth tool that allows for video directly observed therapy of methadone and remote screening for COVID-19 symptoms.
The UW Medical Student Addiction Research (MedStAR) program to address substance use disorders in urban and rural communities in five western states
This project will create a mentored research training program for University of Washington medical students to engage in substance use disorder-focused research and clinical practice during their medical school training.
Patient-centered team-based primary care to treat opioid use disorder, depression, and other conditions (PC2Too)
This project will develop a telephonic collaborative care model for opioid use disorder and depression and then conduct a pragmatic trial to test the model of care management primary care clinics in Washington state and Indiana.
Changing our paths: well-being and recovery among Native Americans with opioid use disorder
This project will characterize an indigenized opioid use disorder “cascade of care” and identify corresponding measures to quantify services and outcomes defined by it.
Alcohol and addiction Research Domain Criteria (AARDoC) and alcohol use disorder recovery
This project will integrate and analyze datasets from multisite clinical trials of alcohol use disorder treatments to understand alcohol addiction research domain criteria (AARDoC) phenotypes and biopsychosocial predictors of alcohol use disorder recovery up to three and ten years following treatment.
Communication and Recovery Enhancement (CARE) clinical trial
This study aims to refine and test a brief intervention (CARE) that aims to promote recovery in recent sexual assault survivors. CARE is delivered to supporters of sexual assault survivors (e.g., friends, family members, romantic partners), with or without the survivor present. It aims to encourage conversations about the assault and decrease negative reactions by the supporter. In stage 1 of this study, we will conduct feedback sessions with 8-10 dyads of survivors and their supporters to finalize the intervention materials. In stage 2, we will conduct a pilot clinical trial of CARE with 60 dyads, who will be randomized to dyadic intervention, supporter-only intervention, or waitlist control.
Intervention to increase naloxone engagement and distribution in community pharmacies
This multi-site study will test the efficacy of an intervention to train and equip pharmacists to provide naloxone, an overdose antidote, to patients using prescribed and illicit opioids, to improve opioid safety and prevent opioid-involved adverse events. The study will carry out a stepped-wedge, cluster randomized trial implemented over five waves, within two chain community pharmacies across four states with varying pharmacy-based naloxone distribution laws: Oregon, Washington, Massachusetts and New Hampshire.
Our specific study aims are to: 1) integrate two successful demonstration research projects into one cohesive educational program (MOON+), 2) evaluate the effectiveness of MOON + on naloxone-related outcomes, and 3) use mixed methods to further explore the impact and implementation of MOON+ and associated factors (e.g., state policy, store policy, region).
Project THRIVE pilot
This study involved developing and preliminarily testing a new app to prevent PTSD and alcohol misuse following recent sexual assault.
Validating a DSM-5 Substance Use Disorder (SUD) symptom checklist
This research will test the psychometric performance of a patient-report questionnaire that assesses DSM-5 substance use disorder symptoms as part of routine primary care.
